Therini Bio

Biotechnology company focused on developing therapeutics for neurodegenerative diseases and age-related conditions. Raised $39 million in Series A funding in May 2025.

Location
Boston, Massachusetts, USA
Founded
2022
Investors
1
Categories
therapeutics, biotech, longevity-research, neurodegenerative, aging

Investors

NameLocationTypeStagesPortfolio
Apollo Health VenturesDusseldorf, Germany / Boston, USAbiotech-focused
seedseries-a+1
15